Clinical Trial Update: Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation [Phase 2]

View source ↗

Summary

Phase 2 trial update on linaclotide for safety and efficacy in 2 to 5-year-olds with functional constipation; completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Constipation

Drugs mentioned

• Linaclotide (linaclotide)

Snippet

Sponsor: Allergan | Conditions: Functional Constipation | Phase 2 | Status: COMPLETED | Results posted: 2022-04-26